Matsushima, Akira http://orcid.org/0000-0001-7496-8995
Maruyama, Yoichi
Mizukami, Noriaki
Tetsuya, Mikio
Hashimoto, Minoru
Yoshida, Kunihiro
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP17hk0102048-19hk0102048)
Article History
Received: 8 June 2021
Accepted: 28 August 2021
First Online: 8 September 2021
Declarations
:
: Study procedures were approved by the Ethics Committee of Shinshu University School of Medicine (No. 3999), and registered in Japan Registry of Clinical Trials (No. 032180164: ExternalRef removed) on Feb. 27, 2019. All the participants were provided with all necessary information about the study, and gave us written informed consent before the clinical trials. All aspects of the study conformed to the principles described in the Declaration of Helsinki.
: Not applicable.
: Dr. Matsushima, Mr. Maruyama and Mr. Tetsuya have no competing interests. Dr. Mizukami is funded by Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists). Dr. Hashimoto is funded by Japan Society for the Promotion of Science grants [Grant-in-Aid for Scientific Research (C) and Challenging Research (Exploratory)], was funded by Japan Society for the Promotion of Science grants [Grant-in-Aid for Scientific Research (B)], Tokyo Metropolitan Industrial Technology Research Institute grants (Robot industry activation business), and AMED grants (Robot care equipment development and standardization business). Dr. Yoshida is funded by Health and Labour Sciences Research Grants (Research Committee of the Ataxia, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, The Ministry of Health, Labour, and Welfare, Japan).